Cholangiopancreatography, Endoscopic Retrograde Clinical Trial
Official title:
Randomized Trial of Spyglass Guided Laser Lithotripsy Versus Dilation-Assisted Stone Extraction for the Endoscopic Removal of Difficult Large Bile Duct Stones
Very large bile duct stones are difficult to remove. Dilation-assisted stone extraction,
also termed small endoscopic sphincterotomy plus endoscopic papillary large balloon
dilatation, is safe and effective technique for the treatment of large CBD stones. However,
in approximately 5-10% of patients, the removal of large bile duct stones may be difficult.
For this selected group of patients for whom all conventional endoscopic stone treatment
devices have failed, laser lithotripsy technology has provided an approach to the
fragmentation of difficult bile duct stones.
A single-operator cholangioscopy (SOC) system (SpyGlass Direct Visualization System, Boston
Scientific Corp., Natick, MA, USA) has overcome most of the conventional cholangioscopy
limitations. The investigators aimed to evaluate the efficacy and safety of Spyglass-guided
laser lithotripsy for difficult CBD stones not amenable to conventional dilation-assisted
stone extraction therapy.
Purpose Very large bile duct stones are difficult to remove.Dilation-assisted stone
extraction, also termed small endoscopic sphincterotomy plus endoscopic papillary large
balloon dilatation, is safe and effective technique for the treatment of large CBD
stones.However, in approximately 5-10% of patients, the removal of large bile duct stones
may be difficult. For this selected group of patients for whom all conventional endoscopic
stone treatment devices have failed, laser lithotripsy technology has provided an approach
to the fragmentation of difficult bile duct stones.
A single-operator cholangioscopy (SOC) system(SpyGlass Direct Visualization System, Boston
Scientific Corp., Natick, MA, USA) has overcome most of the conventional cholangioscopy
limitations.We aimed to evaluate the efficacy and safety of Spyglass-guided laser
lithotripsy for difficult CBD stones not amenable to conventional dilation-assisted stone
extraction therapy.
Study Type: Interventional Study Design: Allocation: Randomized Endpoint Classification:
Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind
(Subject) Primary Purpose: Treatment Official Title: Randomized Trial of Spyglass Guided
Laser Lithotripsy Versus Dilation-Assisted Stone Extraction for the Endoscopic Removal of
Difficult Large Bile Duct Stones
Primary Outcome Measures:
• Bile Duct Stone Clearance Confirmation that no further stones remain in the bile duct of
the patient by cholangiography. Additionally, serum laboratory abnormalities in AST, ALT,
Alkaline Phophatase, or bilirubin, or epigastric abdominal pain attributable to bile duct
stones.
Secondary Outcome Measures:
- Number of ERCP
- The number of ERCP procedures required to complete clearance of bile duct stones.
- Total Procedure Time
- The total time in minutes for all the ERCP procedures required for stone removal.
- Estimated Procedure Cost
- The cost of patient management for bile duct stones based on the cost of the procedure,
hospitalization, and associated costs of complications of cholangitis, pancreatitis,
perforation, and bleeding.
- Cholangitis Cholangitis after or between ERCP procedures will be defined as a
presentation with epigastric abdominal pain, temperature greater than 38.5 Celsius
accompanied by either laboratory abnormalities of the AST, ALT, Alkaline Phosphatase,
or Bilirubin or abnormal imaging of the biliary tree on ultrasound,computed tomography
scan, or magnetic resonance cholangiopancreatography.
- Pancreatitis
- Pancreatitis following or between ERCP procedures will be defined as the onset of
epigastric abdominal pain and either amylase or lipase greater than 3 times the upper
limit of normal or findings on ultrasound, computed tomography scan, or magnetic
resonance cholangiopancreatography suggestive of pancreatic inflammation.
- Bleeding
- Bleeding attributable to stone therapy will be defined as a drop in hemoglobin by more
than 1 gm/dl following or between ERCP procedures with no other cause identified on
standard clinical evaluation.
Eligibility
Ages Eligible for Study: 18 Years and older Genders Eligible for Study: Both Accepts Healthy
Volunteers: No Criteria
Inclusion Criteria:
• Bile duct stone >1.5cm demonstrated on ultrasound, computed tomography, or magnetic
resonance imaging
Exclusion Criteria:
- Biliary, gallbladder or pancreatic malignancy
- Pregnant
- Prior biliary diversion surgery
- Under age 18
- Unable to give informed consent
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05035433 -
Effect of the Sequence of Dilatation and Lithotripsy on the Treatment of Choledocholithiasis With ERCP
|
N/A | |
Completed |
NCT02985164 -
Radiation Exposure During Endoscopic Retrograde Cholangiopancreatography
|
Phase 3 | |
Completed |
NCT05533944 -
Fast-tracking ERCP Learning: Does Training on a Mechanical Simulator Improve Trainee's Clinical Performance?
|
N/A | |
Suspended |
NCT04559867 -
Fistulotomy as the Primary Cannulation Technique for All Patients Undergoing ERCP: A Randomized, Controlled Trial
|
N/A | |
Active, not recruiting |
NCT05592795 -
Explore the Effects and Mechanisms of ERCP and EST on Biliary Microecology
|
||
Enrolling by invitation |
NCT04572711 -
Prospective Evaluation of Biliary Tissue Sampling With ERCP
|
||
Enrolling by invitation |
NCT04719117 -
Retrograde Cholangiopancreatography AI Assisted System Validation on Effectiveness and Safety
|
||
Completed |
NCT03263481 -
Intraductal Secretin Stimulation Test: What Is the Proper Collection Time?
|
N/A | |
Completed |
NCT03292627 -
Non-invasive Monitor in Endoscopic Invasive Procedure
|
||
Recruiting |
NCT06265311 -
IDUS in CBD Stone Recurrence High Risk Patients
|
N/A | |
Completed |
NCT06031363 -
The Optimal Dose of Indomethacin Suppository for Preventing Post-ERCP Pancreatitis
|
N/A | |
Recruiting |
NCT05261997 -
Endotherapy for Painless Chronic Pancreatitis
|
N/A | |
Completed |
NCT02698137 -
Quality Assessment in Endoscopic Retrograde Cholangiopancreatography(ERCP)
|
||
Recruiting |
NCT04910087 -
The Effect of Anesthesia Management on Optic Nerve Sheath Diameter in the Ercp Procedures
|
N/A | |
Recruiting |
NCT05246657 -
EUS-guided Entero-biliary Anastomosis for Therapeutic Access in Benign Biliary Obstructions
|
||
Recruiting |
NCT05303662 -
Prevalence of Multidrug Resistant Micro-organism Carriage in Patients Undergoing an ERCP in Four Different Countries
|
||
Terminated |
NCT05129449 -
A Clinical Study With the Medical Device PowerSpiral for Endoscopic Retrograde Cholangio-Pancreatography (ERCP)
|
||
Completed |
NCT03561441 -
Tailored Hydration for the Prevention of Post-ERCP Pancreatitis
|
N/A | |
Not yet recruiting |
NCT06196164 -
A RCT of Low MBO Drainage Strategies
|
N/A | |
Terminated |
NCT01792466 -
RCT of the Double Wire Technique for Sphincterotomy
|
N/A |